Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene

Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene

Dominant deafness-onychodystrophy (DDOD) syndrome is a rare autosomal dominant disorder caused by mutations in ATP6V1B2 gene. We previously generated an induced pluripotent stem cell (iPSC) line (CPGHi002-A) from a DDOD patient with a heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Here we...

Full description

Bibliographic Details
Main Authors:	Xue Gao, Shi–Wei Qiu, Wei-Qian Wang, Dong-Yang Kang, Ning Su, Pu Dai, Yong–Yi Yuan
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506121001173

Similar Items

Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2
by: Xue Gao, et al.
Published: (2020-10-01)

Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9
by: Hongyang Wang, et al.
Published: (2022-04-01)

Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene
by: Henriette R. Frederiksen, et al.
Published: (2019-03-01)

Establishment of an iPSC line (CPGHi005-A) from a patient with Waardenburg syndrome carrying a heterozygous SVA-F retrotransposon insertion into SOX10
by: Xiaohong Li, et al.
Published: (2022-07-01)

Generation of gene-corrected isogenic control cell lines from a DYT1 dystonia patient iPSC line carrying a heterozygous GAG mutation in TOR1A gene
by: Masuma Akter, et al.
Published: (2022-07-01)

Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing
by: Robert J. Barndt, et al.
Published: (2021-10-01)

Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9
by: Xiaofang Sun, et al.
Published: (2021-04-01)

Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene
by: C. Pavan, et al.
Published: (2023-12-01)

Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line
by: Xiaoli Ji, et al.
Published: (2020-12-01)

Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene
by: Shengru Mao, et al.
Published: (2023-12-01)

Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy
by: Mariana A. Argenziano, et al.
Published: (2021-05-01)

Generation of iPSC line from a Joubert syndrome patient with compound heterozygous mutations in CPLANE1 gene
by: Mazzotta C., et al.
Published: (2024-02-01)

An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene
by: Xinsheng Chen, et al.
Published: (2020-08-01)

Generation of an isogenic gene-corrected iPSC line (PUMCHi001-A-1) from a familial partial lipodystrophy type 2 (FPLD2) patient with a heterozygous R349W mutation in the LMNA gene
by: Cheng Xiao, et al.
Published: (2020-04-01)

Verification of an iPSC line (LZUi002-A) from a patient with a novel mutation in the TBL1X gene
by: Yanli Wang, et al.
Published: (2022-05-01)

Generation of two human isogenic iPSC lines from fetal dermal fibroblasts
by: Rashmi Tandon, et al.
Published: (2018-12-01)

Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C
by: K.R. Valetdinova, et al.
Published: (2020-10-01)

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
by: Thomas L. Maurissen, et al.
Published: (2024-01-01)

Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease
by: Raleigh M. Linville, et al.
Published: (2022-06-01)

Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation
by: Michelle Hua, et al.
Published: (2024-04-01)

Generation of a gene-corrected human iPSC line (CSUASOi004-A-1) from a retinitis pigmentosa patient with heterozygous c.2699 G>A mutation in the PRPF6 gene
by: Yuqin Liang, et al.
Published: (2022-10-01)

Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene
by: David Cunningham, et al.
Published: (2023-09-01)

Generation and characterization of two iPSC lines carrying heterozygous or homozygous nonsense mutation in PROM1 gene from a single family
by: Ping Xu, et al.
Published: (2022-10-01)

Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 gene
by: Osele Ciampi, et al.
Published: (2018-12-01)

The <i>ATP6V1B2</i> DDOD/DOORS-Associated p.Arg506* Variant Causes Hyperactivity and Seizures in Mice
by: Justine Rousseau, et al.
Published: (2023-07-01)

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line
by: Benjamin Schmid, et al.
Published: (2019-01-01)

Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination
by: Seo-Young Lee, et al.
Published: (2019-12-01)

Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene
by: SiJun Li, et al.
Published: (2022-10-01)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
by: Lichao Liu, et al.
Published: (2021-05-01)

Generation of two isogenic iPSC lines from a healthy male donor of European ancestry
by: S. Edwards, et al.
Published: (2024-06-01)

Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics
by: Catarina Dias, et al.
Published: (2022-06-01)

Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9
by: Chun-Lin Liu, et al.
Published: (2020-05-01)

Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene
by: Henriette R. Frederiksen, et al.
Published: (2019-01-01)

Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene
by: Eltahir Ali, et al.
Published: (2020-12-01)

Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
by: Ryan, Scott D., et al.
Published: (2016)

Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient
by: Peter J. Houweling, et al.
Published: (2021-07-01)

An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene
by: Dong Cheng, et al.
Published: (2022-08-01)

Generation of an iPSC line (SCTCi015-A) and isogenic control line (SCTCi015-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene
by: Sarah de Jong, et al.
Published: (2022-07-01)

Generation of an iPSC line (SCTCi014-A) and isogenic control line (SCTCi014-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene
by: Sarah de Jong, et al.
Published: (2022-07-01)

Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
by: Nikita Kozhushko, et al.
Published: (2023-06-01)